Glenmede Trust CO Na Ligand Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $234,745 - $332,010	-2,294 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $5,651 - $7,781	-50 Reduced 2.13%	2,294 $300,000
Q1 2021 May 18, 2021	SELL	$99.52 - $215.83 $170,676 - $370,148	-1,715 Reduced 42.25%	2,344 $357,000
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $28,111 - $37,011	349 Added 9.41%	4,059 $403,000
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $37,256 - $52,715	416 Added 12.63%	3,710 $352,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $56,740 - $102,753	831 Added 33.74%	3,294 $368,000
Q4 2019 Feb 12, 2020	BUY	$96.94 - $113.59 $19,872 - $23,285	205 Added 9.08%	2,463 $256,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $108,588 - $151,281	-1,259 Reduced 35.8%	2,258 $224,000
Q2 2019 Aug 13, 2019	BUY	$107.38 - $129.34 $23,516 - $28,325	219 Added 6.64%	3,517 $400,000
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $29.3 Million - $39.4 Million	-276,876 Reduced 98.82%	3,298 $413,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $13.3 Million - $28.3 Million	103,927 Added 58.97%	280,174 $38 Million
Q3 2018 Nov 15, 2018	SELL	$211.18 - $274.49 $37.9 Million - $49.2 Million	-179,379 Reduced 50.44%	176,247 $48.4 Million
Q2 2018 Aug 15, 2018	SELL	$150.77 - $207.98 $5.62 Million - $7.76 Million	-37,306 Reduced 9.49%	355,626 $73.7 Million
Q4 2017 Feb 15, 2018	BUY	$128.36 - $147.04 $10.3 Million - $11.8 Million	80,040 Added 25.58%	392,932 $53.8 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $37.8 Million - $43.2 Million	312,892	312,892 $0

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.